MAPRACORAT

SynDRA canonical compound SYN0030074 — structure-anchored drug synonym record

Clinical phase	Phase 3
Primary target(s)	CXCL8 \| MYOC \| NR3C1
Mechanism of action	glucocorticoid receptor agonist
Indication	cataracts
Disease area	ophthalmology

All known targets

NR3C1
CXCL8
MYOC

Mechanisms of action (all sources)

NR3C1 AGONIST

Cross-references

PubChem CID: 24795088
ChEMBL: CHEMBL2103876
DrugBank: DB12041
ChEBI: 177650
KEGG: D10136
Wikipedia: Mapracorat
TTD: D01IUS

Synonyms

ZK-245186
BOL-303242-X
BOL-303242X
ZK245186
SEGRA, Intendis
SEGRA, Schering AG
ZK-216348
ZK-238587
Mapracorat (ophthalmic, ocular inflammation)
Mapracorat Ophthalmic Suspension, Bausch & Lomb
SEGRA (atopic dermatitis), Bayer
Selective glucocorticoid receptor agonists (SEGRA) Bayer Schering/AstraZeneca
Selective glucocorticoid receptor agonists (SEGRA) Schering AG/AstraZeneca
Selective glucocorticoid receptor agonists (SEGRA), Schering AG
Selective glucocorticoid receptor agonists (dermatology), Schering AG
Mapracorat (dermatological, atopic dermatitis), Intendis
SEGRA (ophthalmic disease), Bausch & Lomb
Selective glucocorticoid receptor agonist (ophthalmic disease), Bausch & Lomb
Selective glucocorticoid receptor agonists (dermatological, eczema), Intendis
Suppressor of pro-inflammatory mediators (eczema), Intendis
BOL-303242-X Ophthalmic Suspension, Bausch & Lomb
Mapracorat (ophthalmic, ocular inflammation), Bausch & Lomb
ZK-245186 (ophthalmic), Bausch & Lomb
BOL 303242-X
ZK 245186
mapracoratum
BOL303242-X
RefChem:155760
DTXCID101514796
Mapracorat [USAN]
Mapracorat (USAN)
ZK-245186;BOL-303242X
Mapracorat [USAN:INN]
UNII-145V79YBVP
MAPRACORAT [INN]
GTPL9654
SCHEMBL1877067
SCHEMBL29367060
SCHEMBL31390395

Look up MAPRACORAT in the interactive SynDRA portal →